公司2021年半年度报告封面名字为“OVCTEK”,公司简介名称为“AFTEK”. 欧普康视(300595.SZ)10月11日在投资者互动平台表示,公司英文名称为:Autek China Inc.,OVCTEK 是公司注册的商标。 (记者 王晓波) 免责声明:本文内容与数据仅供参考,不构成投资建议,使用前核实。据此操作,风险自担。 每日经济新闻 举报/反馈 ...
公司2021年半年度报告封面名字为“OVCTEK”,公司简介名称为“AFTEK”. 欧普康视(300595.SZ)10月11日在投资者互动平台表示,公司英文名称为:Autek China Inc.,OVCTEK 是公司注册的商标。 (记者 王晓波) 免责声明:本文内容与数据仅供参考,不构成投资建议,使用前核实。据此操作,风险自担。 每日经济新闻...
公司英文名称为:Autek China Inc.,OVCTEK 是公司注册的商标。谢谢! 欧普康视2021中报显示,公司主营收入5.7亿元,同比上升91.94%;归母净利润2.56亿元,同比上升100.09%;扣非净利润2.11亿元,同比上升89.6%;负债率15.7%,投资收益5735.83万元,财务费用342.83万元,毛利率76.49%。 欧普康视主营业务:三类医用光电仪器类、医用...
公司英文名称为:Autek China Inc.,OVCTEK 是公司注册的商标。谢谢!
Ovctek China Inc mainly engages in rigid gas permeable contact lenses and the medical industry, accounting for 96.33% and 13.67% of its revenue in 2021, respectively. Ovctek China Inc's general manager and chairman is Tao Yuequn, male, 62 years old, PhD. ...
NBD AI Bulletin -OVCTEK China Inc (the Company, SZ 300595, close price: 73.47 yuan) on October 14 said that as at the disclosure of this notice, Nanjing Outao Information Technology Co Ltd has cumulatively pledged about 10.06 million shares, accounting for 8.19% of its holdings in the Compa...
每经AI快讯,有投资者在投资者互动平台提问:请问贵公司的英文名称是什么?公司2021年半年度报告封面名字为“OVCTEK”,公司简介名称为“AFTEK”. 欧普康视(300595.SZ)10月11日在投资者互动平台表示,公司英文名称为:Autek China Inc.,OVCTEK 是公司注册的商标。 (记者 王晓波)...
NBD AI Bulletin --OVCTEK China INC (SZ 300595, close price: 34 yuan) on April 10 announced that as of the date of the announcement, the guarantee of the Company and its subsidiaries amounted to around 6 million yuan. OVCTEK China Inc's general manager and chairman is Tao Yuequn, male,...
NBD AI Bulletin --Ovctek China Inc(SZ 300595, closing price: 86.78 yuan) onJanuary 19 released a performance forecast, saying that in 2020, the Company's net profit attributable to shareholders is expected to be399 million yuan ~460 million yuan, up30%~50% year over year; the basic earni...
Ovctek China Inc's chairman and general manager is Tao Yuequn, male, 62 years old, PhD. (By Tan Yuhan) Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on th...